Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)
Central sleep apnoea (CSA) is a sleep disorder characterized by the repeated cessation or reduction of both airflow and ventilatory effort when sleeping. Individuals with central breathing disorders have difficulty in receiving appropriate medical treatment. In this article, we describe a case study...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2023-11-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/sleep-related-breathing-disorder-central-sleep-apnoea-improved-coincidentally-by-medical-therapy-with-fumarates-dimethyl-fumarate/ |